ITI Inc (ITCI) reported quarterly earnings results on Thursday, Aug-4-2016. The company said it had a profit of $-0.71 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.08. Analysts had a consensus of $-0.79. The company posted revenue of $.23 million in the period, compared to analysts expectations of $.02 million. The company’s revenue was up 283.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.61 EPS.
Many Wall Street Analysts have commented on ITI Inc. ITI Inc was Initiated by Piper Jaffray to “Overweight” on Jun 2, 2016.
ITI Inc closed down -0.26 points or -0.63% at $40.98 with 3,52,442 shares getting traded on Tusday. Post opening the session at $41.15, the shares hit an intraday low of $40.4087 and an intraday high of $41.53 and the price fluctuated in this range throughout the day.Shares ended Tusday session in Red.
In a different news, on Apr 20, 2016, Rory B Riggs (director) purchased 28,571 shares at $17.50 per share price. According to the SEC, on Dec 15, 2015, Sharon Mates (Chairman, President & CEO) sold 51,500 shares at $54.29 per share price. On Dec 15, 2015, Lawrence J. Hineline (VP of Finance CFO) sold 45,000 shares at $51.56 per share price, according to the Form-4 filing with the securities and exchange commission.
ITI Inc. is a United States-based company. The Company is a subsidiary of Intra-Cellular Therapies Inc.